Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and $370M-$380M for FY24.
Related Keywords
Yossi Carmil , Dana Gerner , Cellebrite Di Ltd , Israel Innovative Technology , Recurring Revenue , Innovative Technology ,
comparemela.com © 2020. All Rights Reserved.